UNC Lineberger researchers Hy Muss, MD, Shlomit Strulov Shachar, MD, and colleagues report in the journal Clinical Cancer Research that a measure of muscle mass and muscle quality developed at UNC could potentially help doctors better identify patients at high risk for side effects that could require hospitalization.
Attention all nurses: the Annual Certified Nurses Day Celebration will be held on March 15, 2017.
All are welcome to this Clinical Ethics Grand Rounds panel presentation. Panel members are Arlene Davis, JD; Sarah Fotheringham, JD; Benny Joyner, MD, MPH; and Gary Winzelberg, MD, MPH, FACP.
The National Association of Health Service Executives (NAHSE) and Toastmasters are hosting a free public speaking class on March 23 at 6 p.m.
The UNC’s Food Allergy Initiative is conducting an industry-sponsored phase one clinical trial for peanut allergy. The purpose of this study is to find out if an investigational treatment for peanut allergy is safe and tolerable for people suffering from peanut allergy.
Published last week in the journal Nature, the research shows it is possible to use MRIs to predict which high-risk babies will go on to develop autism as toddlers.
Results published in JAMA Surgery reinforce the importance of communication, teamwork, and professionalism during patient care.
Published today in Nature, the discovery has major implications for the study of motivation, decision making, as well as addiction and other disorders.
Free books! Please join us in the Children's Hospital lobby for the Lending Library Spring Book Event on Tuesday, March 21, from 11 a.m. - 2 p.m.
In their study of the IRS-1 protein, researchers at the University of North Carolina found a new lead for reversing or preventing heart disease associated with diabetes.
During the evenings of Friday and Saturday, Feb. 24 – 25, and Friday and Saturday, March 3 – 4, Plant Engineering will replace the light fixtures in the lobby of the Women’s Hospital. If necessary, this work may extend to the evenings of Friday and Saturday, March 10 – 11.
Effective Feb. 17, UNC McLendon Clinical Laboratories (MCL) Immunology Laboratory will switch to Bio-Rad Geenius HIV supplemental assay.
A study led by UNC Lineberger researcher Ronald Chen, MD, found that a group of prostate cancer patients reliably reported their own medical histories when their responses were compared to their medical records.
With a $1.74 million grant from the NIH, UNC Lineberger researchers led by H. Shelton Earp, MD, will study a potential new strategy for improving immunotherapy drug responses in patients with melanoma.